Skip to main content

Day: October 13, 2022

Enovis to Host Third Quarter 2022 Conference Call on November 2nd

Wilmington, DE, Oct. 13, 2022 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2022 financial results on Wednesday, November 2, 2022 at 8:00AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section. Conference call/Webcast Information Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and provide the conference ID 1914045. A link to a replay of the call will also be available on the Enovis website later that...

Continue reading

Concentrix Ranked Among the World’s 25 Best Workplaces by Great Place to Work and Fortune magazine

Company also Ranked Tenth in Best Workplaces in Latin America NEWARK, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) — Concentrix Corporation (Nasdaq: CNXC), a leading global provider of customer experience (CX) solutions and technologies, announced today that it has earned a position for the first time on the 25 World’s Best Workplaces™ list by Great Place to Work® and Fortune Magazine, ranking twenty-second. Great Place to Work, the global authority on workplace culture, selected the list using rigorous analytics and confidential employee feedback, including the voices of 14.8 million employees worldwide. The companies that earn a position on the list are chosen for creating globally exceptional employee experiences, high-trust relationships, and workplaces that are fair and equal for all. “We are so grateful for all of our incredible...

Continue reading

Form 8.3 – Octopus Investments – The British Honey Company plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: OCTOPUS INVESTMENTS LTD(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree The British Honey Company plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position...

Continue reading

ADT Announces Closing of $1.2 Billion Equity Investment by State Farm

Partnership, including $300 million opportunity fund commitment by State Farm, revolutionizes the customer experience by combining security, risk mitigation and smart home capabilities State Farm Chief Operating Officer Paul Smith appointed to ADT Board of Directors BOCA RATON, Fla., Oct. 13, 2022 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT), the most trusted brand in smart home and small business security, today announced that it has issued and sold in a private placement to State Farm 133.3 million shares of ADT common stock for a gross purchase price of $1.2 billion. In September, ADT announced a new partnership with State Farm to revolutionize the homeownership experience through innovation in the detection and mitigation of property losses. In addition to the equity investment, State Farm has committed up to $300 million to fund...

Continue reading

Diana Shipping Inc. Announces Delivery of the Ultramax Dry Bulk Vessel m/v DSI Pyxis and Entry Into Time Charter Contract With Cargill Ocean Transportation

ATHENS, Greece, Oct. 13, 2022 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has taken delivery of the m/v DSI Pyxis (formerly “STH Montreal”), a 2018 built Ultramax dry bulk vessel of 60,362 dwt. The vessel is one of nine modern Ultramax dry bulk vessels that the Company entered into an agreement to purchase in August 2022. The Company also announced that, through the same wholly-owned subsidiary, it entered into a time charter contract with Cargill Ocean Transportation Singapore Pte. Ltd. at a gross charter rate of US$17,100 per day, minus a 4.75% commission paid to third parties, for a period of minimum ten (10) months to maximum twelve...

Continue reading

Merit Medical Systems to Announce Third Quarter Results on October 26, 2022

SOUTH JORDAN, Utah, Oct. 13, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2022, after the close of the stock market on Wednesday, October 26, 2022. Merit will hold its investor conference call on the same day (Wednesday, October 26, 2022) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at merit.com.   ABOUT MERIT Founded...

Continue reading

Volcon Announces Exclusive Co-Branding and Distribution Partnership with Torrot Electric Europa

Volcon Torrot Motocross 2 Volcon adds co-branded Torrot Motocross 2 to its lineup.Volcon Torrot Supermoto 2 and Trial 2 Volcon adds co-branded Torrot Supermoto 2 and Trial 2 to future product offering.AUSTIN, Texas, Oct. 13, 2022 (GLOBE NEWSWIRE) — Volcon Inc. (NASDAQ: VLCN) (“Volcon” or the “Company”), the first all-electric, off-road powersports company, announced today that it has signed an exclusive co-branding and distribution agreement with Torrot Electric Europa, S.A. Volcon will be granted exclusive rights to sell the new range of youth motorcycles throughout the United States, Caribbean Community countries and dependencies, as well as Central and South America. The motorcycles will be built by Torrot at their facility near Barcelona, Spain. The three year agreement will provide Volcon with an immediate entry into...

Continue reading

IntelGenx’s Collaboration with atai Life Sciences Culminates in the Initiation of First-in-Human Clinical Study of an Oral Thin Film Psychedelic Drug Candidate

SAINT LAURENT, Quebec, Oct. 13, 2022 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today provided an update on its collaboration with its strategic partner, atai Life Sciences (NASDAQ:ATAI) (“atai”), for the development of novel formulations of pharmaceutical-grade psychedelics based on IntelGenx’s polymeric film technologies. Pursuant to the first of two current feasibility agreements between the companies, IntelGenx conducted pre-development, formulation development work and clinical supply manufacturing to provide a product prototype to atai for further clinical investigation. That previously undisclosed candidate, buccal VLS-01, is a buccal film containing a synthetic form of N,N-dimethyltryptamine. atai is developing the product as a novel therapy for...

Continue reading

Signature of Framework Agreement Between the Fiat Brand and the Algerian Authorities Aimed at Local Production of Vehicles

Signature of Framework Agreement Between the Fiat Brand and the Algerian Authorities Aimed at Local Production of Vehicles and the Development of the Automotive Sector in Algeria AMSTERDAM, Oct. 13, 2022 – A framework agreement was signed on today in Algiers between Mr. Samir Cherfan, Chief Operating Officer of Middle East & Africa region of Stellantis, and Mr. Boussoussa Zineddine, Director of Cooperation of the Algerian Ministry of Industry. This framework agreement covers a project for the development in Algeria of industrial, after-sales and spare parts activities for Fiat, one of the emblematic brands of Stellantis, as well as the development of the automotive sector in Algeria. This ceremony was chaired by Mr. Ahmed Zaghdar Algerian Minister of Industry and Mr. Carlos Tavares Chief Executive Officer of Stellantis in the presence...

Continue reading

Cassava Sciences Announces Initiation of an Open-label Extension Study

Alzheimer’s Patients Who Complete Participation in a Phase 3 Study of Simufilam are Eligible to Enroll 52-week Study of Simufilam 100 mg Up to 1,600 Patients Are Expected to EnrollAUSTIN, Texas, Oct. 13, 2022 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the initiation of an open-label extension study. This study is designed to provide no-cost access to simufilam, an investigational drug, to patients with Alzheimer’s disease who complete either one of Cassava Sciences’ on-going Phase 3 studies, which are double-blind, placebo-controlled trials. “We believe this open-label study is the right thing to do,” said Remi Barbier, President & CEO. “Alzheimer’s patients who complete one of our Phase 3 studies are eligible to enroll,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.